[Retracted] Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma

Table 4

Comparison of peripheral neuritis grades in newly treated patients.

Peripheral neuritis grade	Newly treated original research drug group (n = 127)	Newly treated generic drug group (n = 102)
1	9 (0.07)	7 (0.07)	0.595
2	20 (0.16)	10 (0.10)
3	13 (0.10)	10 (0.10)
4	0	0